The mRNA and protein expressions and distribution of PCNA in the prostate were also upregulated in the BPH model group comparing with the sham-operated group, which were then suppressed in CS group (Figures 4(d), 4(e), and 4(f)). The gene discussed is PCNA; the disease is benign prostatic hyperplasia.